{"id":"W2244529370","doi":"10.1200/jco.2009.27.15_suppl.1022","title":"Pertuzumab monotherapy following trastuzumab-based treatment: Activity and tolerability in patients with advanced HER2- positive breast cancer","year":2009,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Pertuzumab; Trastuzumab; Medicine; Tolerability; Internal medicine; Oncology; Metastatic breast cancer; Adverse effect; Breast cancer; Cancer; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001202703,0.0001930356,0.001554859,0.0001319067,0.00004511292,0.00001128082,0.00009701146,0.0002539939,0.00007252801],"category_scores_gemma":[0.0003539949,0.0001236634,0.0002882431,0.0001819804,0.0001686198,0.0001721084,0.000009363599,0.000819459,8.918722e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001743191,"about_ca_system_score_gemma":0.002855559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002386572,"about_ca_topic_score_gemma":0.0003086001,"domain_scores_codex":[0.997263,0.000555268,0.001061685,0.0003107999,0.0004782831,0.0003310071],"domain_scores_gemma":[0.9973457,0.001176313,0.0005769065,0.0001899782,0.000314169,0.0003968771],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.02542183,0.003702798,0.4704886,0.00000740219,0.0001234114,0.0001677311,0.0001034226,0.00004547987,0.00008322527,9.613908e-7,0.00001485611,0.4998403],"study_design_scores_gemma":[0.03011686,0.05221331,0.9162807,0.0002462883,0.0001068904,0.00002678271,0.00003092231,0.0001640475,0.0001337954,0.00003119785,0.0005453129,0.0001038902],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862758,0.0002414247,0.0000519266,0.01239579,0.0001963714,0.0005382972,0.0000167145,0.000007571236,0.000276097],"genre_scores_gemma":[0.9970405,0.0003024792,0.0009584936,0.00143927,0.0002040612,0.00001163237,0.000001719403,0.00001742182,0.0000244379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4997364,"threshold_uncertainty_score":0.506564,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06210822724411943,"score_gpt":0.4834389207595168,"score_spread":0.4213306935153974,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}